FDA Inspection 820394 — Affymax, Inc.
The FDA completed an inspection of Affymax, Inc. on March 20, 2013 in Cupertino, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 20, 2013
- Fiscal Year
- 2013
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Cupertino, CA (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)